Patents by Inventor Timothy F. Gallagher

Timothy F. Gallagher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10500708
    Abstract: A power tool is provided including a gear case having a spindle, a motor case connected to a rear end of the gear case, a handle portion attached to a rear end of the motor case, and a motor housed inside the motor case. The motor includes a stator, a rotor rotationally arranged inside the stator, and a fan in rotational connection with the rotor. At least one air intake is arranged at least one of the motor case or the handle portion near the rear end of the motor case. A power module including power switches and a heat sink is housed in at least one of the motor case or the handle portion near the rear end of the motor case such that rotation of the fan causes air flow to enter through the air intake and flow near the heat sink and through the motor.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: December 10, 2019
    Assignee: Black & Decker Inc.
    Inventors: Joseph P. Kelleher, William F. Gallagher, Sean R. Templeton, Mark R. Poetzl, Seth M. Robinson, Marcell E. Coates, Madhur M. Purohit, Timothy J. Seeley, Joshua M. Lewis
  • Patent number: 10298588
    Abstract: A secure communication system comprises a software program client operating on a host computing device, a service manager configured to manage client access to the protected services, an authorizer in communication between the client and the service manager, and a receiver in communication with the service manager and serves as an interface to the protected services. At least one of a browser and an application of the client is configured to access one or more protected services running on a computing device that is remote to the host computing device over a communication channel. The service manager maintains a list of predetermined services authorized for the client and limits client access to the predetermined services.
    Type: Grant
    Filed: July 29, 2015
    Date of Patent: May 21, 2019
    Assignee: BlackSands, Inc.
    Inventors: Dan T. Pawl, Nathan J. Pawl, Timothy F. Gallagher
  • Publication number: 20170230374
    Abstract: A secure communication system comprises a software program client operating on a host computing device, a service manager configured to manage client access to the protected services, an authorizer in communication between the client and the service manager, and a receiver in communication with the service manager and serves as an interface to the protected services. At least one of a browser and an application of the client is configured to access one or more protected services running on a computing device that is remote to the host computing device over a communication channel. The service manager maintains a list of predetermined services authorized for the client and limits client access to the predetermined services.
    Type: Application
    Filed: July 29, 2015
    Publication date: August 10, 2017
    Inventors: Dan T. Pawl, Nathan J. Pawl, Timothy F. Gallagher
  • Patent number: 7612075
    Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: November 3, 2009
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Michael R. Myers, Wan F. Lau, Aiwen Li, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
  • Patent number: 7091204
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: August 15, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
  • Patent number: 7026349
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: April 11, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
  • Patent number: 6849635
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: February 1, 2005
    Assignee: SmithKline Beecham Corporation
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight, Stanley J. Schmidt
  • Publication number: 20040198979
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Application
    Filed: November 7, 2003
    Publication date: October 7, 2004
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
  • Publication number: 20040152895
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Application
    Filed: November 7, 2003
    Publication date: August 5, 2004
    Inventors: Dashyant Dhanak, Timothy F Gallagher, Steven D Knight, Stanley J Schmidt
  • Publication number: 20040152906
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Application
    Filed: November 7, 2003
    Publication date: August 5, 2004
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
  • Publication number: 20040152893
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Application
    Filed: November 7, 2003
    Publication date: August 5, 2004
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D Knight, Stanley J. Schmidt
  • Publication number: 20040152891
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Application
    Filed: November 7, 2003
    Publication date: August 5, 2004
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
  • Publication number: 20040142948
    Abstract: The present invention relates to sulfonamides, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.
    Type: Application
    Filed: November 7, 2003
    Publication date: July 22, 2004
    Inventors: Dashyant Dhanak, Timothy F. Gallagher, Steven D. Knight
  • Publication number: 20040102450
    Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa..
    Type: Application
    Filed: July 25, 2003
    Publication date: May 27, 2004
    Applicant: AVENTIS PHARMACEUTICALS INC.
    Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Aiwen Li, Michael R. Myers, Wan F. Lau, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
  • Publication number: 20030153604
    Abstract: This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.
    Type: Application
    Filed: February 24, 2003
    Publication date: August 14, 2003
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: William P. Dankulich, Daniel G. McGarry, Christopher Burns, Timothy F. Gallagher, Francis A. Volz
  • Patent number: 6541505
    Abstract: This invention is directed to an (aminoiminomethyl or aminomethyl)benzoheteroaryl compound of formula I which is useful for inhibiting the activity of Factor Xa by combining said compound with a composition containing Factor Xa. The present invention is also directed to compositions containing compounds of the formula I, methods for their preparation, their use, such as in inhibiting the formation of thrombin or for treating a patient suffering from, or subject to, a disease state associated with a physiologically detrimental excess amount of thrombin.
    Type: Grant
    Filed: June 30, 2000
    Date of Patent: April 1, 2003
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: William P. Dankulich, Daniel G. McGarry, Christopher Burns, Timothy F. Gallagher, Francis A. Volz
  • Patent number: 6528512
    Abstract: This invention relates to the novel amino substituted pyrimidine compounds of Formulas (I), (II) and (III), and pharmaceutical compositions comprising a compound of these Formulas and a pharmaceutically acceptable diluent or carrier. This invention also relates to a method of inhibiting CSBP kinase and cytokines mediated by this kinase, for the treatment of cytokine mediated diseases, in mammals, by administration of a compound of Formula (I), (II) or (III).
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: March 4, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Timothy F. Gallagher, Susan M. Thompson
  • Patent number: 6361773
    Abstract: This invention relates to drug binding proteins, to genes encoding same and to assays and methods for screening pharmaceuticals. More specifically, this invention relates to a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, to a gene encoding same and to assays and screens useful in the evaluation and characterization of drugs of this pharmacologic class.
    Type: Grant
    Filed: October 1, 1997
    Date of Patent: March 26, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: John C. Lee, Jerry L. Adams, Timothy F. Gallagher, David W. Green, John Richard Heys, Peter C. McDonnell, Dean E. McNulty, Peter R. Young, James E. Strickler
  • Patent number: 6096748
    Abstract: This invention relates to the novel amino substituted pyrimidine compounds of Formulas (I), (II) and (III), and pharmaceutical compositions comprising a compound of these Formulas and a pharmaceutically acceptable diluent or carrier.This invention also relates to a method of inhibiting CSBP kinase and cytokines mediated by this kinase, for the treatment of cytokine mediated diseases, in mammals, by administration of a compound of Formula (I), (II) or (III).
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: August 1, 2000
    Assignee: SmithKline Beecham Corporation
    Inventors: Timothy F. Gallagher, Susan M. Thompson
  • Patent number: 5955366
    Abstract: This invention relates to drug binding proteins, to genes encoding same and to assays and methods for screening pharmaceuticals. More specifically, this invention relates to a Cytokine Suppressive Anti-Inflammatory Drug (CSAID) binding protein, to a gene encoding same and to assays and screens useful in the evaluation and characterization of drugs of this pharmacologic class.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: September 21, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: John C. Lee, Jerry L. Adams, Timothy F. Gallagher, David W. Green, John Richard Heys, Peter C. McDonnell, Dean E. McNulty, James E. Strickler, Peter R. Young